Website is intended for physicians
Search:
Всего найдено: 3

 

Abstract:

Department of Obstetrics and Gynaecology of the Therapeutic and Moscow Faculties of Scientific Research Practical Laboratory of intracardiac and contrast methods of roentgenological studies under the Federal Facility Russian State Medical University of the Russian Ministry of Public Health, Moscow.

This article opens a new series of publications dedicated to a currently important issue of endovascular treatment of uterine myoma - uterine artery embolization (UAE). The authors presently possessing the most abundant hands-on experience in UAE in Russia, based on own experience and literature data discuss herein the most urgent problems related to UAE in treatment for uterine myoma and other obstetrical and gynaecological pathology. Amongst them are the problems of determining the indications for and contraindications to an intervention, outcomes of UAE (including that combined with other therapeutic methods), problems of optimization of the technique and development of technical procedures allowing for UAE to be performed virtually in any situation, as well as the problems related to selection of embolizing substances. The authors also give a detailed consideration to the so-called "myths" about UAE - currently existing negative views on certain aspects of intervention, which are based on outdated and inexact evidence. The authors draw a conclusion that endovascular methods are highly promising in obstetrical and gynaecological pathology.

 

References

1.     Oliver J. A. Jr, Lance J.S. Selective embolization to control massive hemorrhage following pelvic surgery. Am. J. Obstet. Gynecol. 1979; 135: 431-432.

2.     Ravina J., Merland J., Herbreteau D. et al. Preoperative embolization of uterine fibroma. Preliminary results [10 cases] [letter, in French]. Presse Med. 1994; 23: 1540.

3.     Goodwin S., McLucas B., Lee M. et al. Uterine artery embolization for the treatment of uterine leiomyomata midterm results. J. Vasc. Intervent. Radiol. 1999; 10: 1159-1165.

4.     Goodwin S., Vedantham S., McLucas B. et al. Preliminary experience with uterine artery embolization foruterine fibroids. J. Vasc. Interv. Radiol. 1997; 8: 517-526.

5.     Spies J., Scialli A., Jha R. et al. Initial results from uterine fibroid embolization for symptomatic leiomyomata.J.Vasc.Intervent.Radiol. 1999; 10: 1149-1157.

6.     Uterine Artery Embolization Survey: 10,500 Procedures Performed Worldwide, FairfaxVA: Society ofInterventional Radiology. 2000.

7.     Hovsepian D., Siskin G., Bonn J. et al. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. J. Vasc. Interv. Radiol. 2004; 15: 535-542.

8.     Wong G.C., Muir S.J., Lai A.P., Goodwin S.C. Uterine artery embolization: a minimally invasive technique for the treatment of uterine fibroids. J. Womens Health Gend. Based Med. 2000; 4(9): 357-362.

9.     Савельева Г.М., Бреусенко В.Г., Капранов С.А., Краснова И.А., Бобров Б.Ю., Шевченко Н.А., Аксенова В.Б., Алиева А.А. Эмболизация маточных артерий у больных с миомой матки. Акушерство и гинекология. 2004; 5: 21-24.

10.   Worthington-Kirsch R. Uterine artery embolization: state-of-the-art and new developments. Intervention. 2000; 2(4): 35-38.

11.   Beinfeld M.T., Bosch J.L., Isaacson K.B., Gazelle G.S. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology. 2004; 1(230): 207-213.

12.   Al-Fozan H., Dufort J., Kaplow M. et al. Cost analysis of myomectomy, hysterectomy and uterine artery embolization. Am. J. Obstet. Gynecol. 2002; 5(187): 1401-1404.

13.   Капранов С.А., Беленький А.С., Бобров Б.Ю., Доброхотова Ю.Э., Журавлева А.Д., Алиева А.А., Кайфаджан М.М. Эмболизация маточных артерий в лечении миомы матки: 126 наблюдений. Бюллетень НЦ ССХ им. А.Н. Бакулева РАМН «Сердечно-сосудистые заболевания». 2003; 11(4): 219.

14.   Тихомиров А.Л., Лубнин Д.М. Эмболизация маточных артерий в лечении миомы матки. Вопросы гинекологии, акушерства и перинатологии. 2002; 2(1): 83-85.

15.   Билан М.И., Козюра О.П. Эмболизация маточных артерий при миоме матки: особенности катетеризационной техники. Международный журнал интервенционной кардиоангиологии. 2004; 4: 43-46.

16.   Кавтеладзе З.А., Дроздов С.А., Былов К.В. и др. Эмболизация маточных артерий при фибромиоме матки. Международный журнал интервенционной кардиоангиологии. 2005; 7: 55.

17.   Бреусенко В.Г., Краснова И.А., Капранов С.А., Бобров Б.Ю., Аксенова В.Б., Шевченко Н.А., Арютин Д.Г. Некоторые дискуссионные вопросы эмболизации маточных артерий при лечении миомы матки. Акушерство и гинекология. 2006; 3: 23-26.

18.   Коков Л.С., Самойлова Т.Е., Ситкин И.И., Цыганков В.Н., Гус А.И. Динамика редукции миоматозных узлов в зависимости от их локализации у пациенток, перенесших эмболизацию маточных артерий по поводу миомы матки. Материалы конференции «Радиология 2006» 25-27 апреля 2006; 235.

19.   Lohle P.N.M., Lapmann L., Boekkooi F.P., Vervest H.A.MSpecialists collaborate in fibroid treatmentDiagnostic Imaging Europe. 2002; 23-25.

20.   David M., Ebert A.D. Treatment of uterine fibroids by embolization - advantages, disadvantages, and pitfalls. Eur. J.Obstet. Gynecol. Reprod Biol. 2005; 2(122): 144-150.

21.   Nikolic B., Spies J.B., Campbell L. et al. Uterine artery embolization: Reduced radiation with refined technique. J. Vasc. Intervent. Radiol. 2001; (12): 39-44.

22.   Brunereau L., Herbreteau D., Gallas S. et al. Uterine artery embolization in the primary treatment of uterine leiomyomas: technical features and prospective follow-up with clinical and sonographic examinations in 58 patients. AJR. 2000; 175: 1267-1272.

23.   Pelage J., Le Dref O., Soyer P. et al. Arterial anatomy of the female genital tract: Variations and relevance to transcatheter embolization of the uterus. AJR. 1999; 172: 989-994.

24.   Katsumori T., Nakajima K., Mihara T., Tokuhiro M. Uterine artery embolization using gelatin sponge particles alone for symptomatic uterine fibroids: Midterm results. AJR. 2002; 178: 135-139.

25.   Du J., Zuo Y., Chen X. et al. Clinical observation of transcatheter uterine artery embolization for uterine myoma. Zhonghua Fu Chan Ke Za Zhi. 2002; 1(37): 12-15.

26.   Belenky A., Cohen M., Bachar G. Uterine arterial embolization for the management of leiomyomas. IsrMed.Assoc.J. 2001; 10(3): 719-721.

27.   Доброхотова Ю.Э., Капранов С.А., Бобров Б.Ю., Алиева А.А., Гришин И.И. Эмболизация маточных артерий - постэмболизационный синдром. Российский вестник акушера-гинеколога. 2005; 2(5): 44-49.

28.Nagao T., Ohwada T., Kitazono M., Ohshima K., Shimizu H., Katayama MThoracic epidural analgesia is effective in perioperative pain relief for uterine artery embolizationMasui. 2005; 2(54): 156-159.

29.   Saito S., Chiba A., Hayakawa S.,Toyoshima M., Enomoto A. Pain control with epidural anesthesia for uterine artery embolization. Masui. 2004; 4(53): 391-395.

30.   Ryan J.M., Gainey M., Glasson J., DohertyJ., Smith T.P. Simplified pain-control protocol after uterine artery embolization. Radiology. 2002; 2(224): 610-611, discussion 611-613.

31.   Rasuli P., Jolly E.E., Hammond I., French G.J., Preston R., Goulet S., Hamilton L., Tabib M. Superior hypogastric nerve block for pain control in outpatient uterine artery embolization. J. Vasc. Interv. Radiol. 2004; 12(15): 1423-1429.

32.   Keyoung J.A., Levy E.B., Roth A.R. et al. Intraarterial lidocaine for pain control after uterine artery embolization for leiomyomata. JVascIntervRadiol 2001; 9(12): 1065-1069.

33.   Капранов С.А., Бреусенко В.Г., Бобров Б.Ю., Краснова И.А., Шевченко Н.А., Алиева А.А., Аксенова В.Б. Применение эмболизации маточных артерий при лечении миомы матки: анализ 258 наблюдений. Международный журнал интервенционной кардиоангиологии. 2005; 7: 56.

34.   Walker W.J., Pelage J.P. Uterine fibroid embolization: Results in 400 women with imaging follow-up. J. Vasc. Interv. Radiol. 2002; 13 (Suppl. 2): 18.

35.   Доброхотова Ю.Э., Капранов С.А., Алиева А.А., Бобров Б.Ю., Гришин И.ИНовый органосохраняющий метод лечения миомы матки — эмболизация маточных артерийЛечебное дело. 2005; 2: 24—27. 36.Jha R.C., Ascher S.M., Imaoka I., Spies J.B. Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization. Radiology. 2000; (217): 228-235.

37.   Бреусенко В.Г., Краснова И.А., Капранов С.А., Аксенова В.Б., Бобров Б.Ю., Шевченко Н.А. Спорные вопросы эмболизации маточных артерий при миоме матки. Вопросы гинекологии, акушерства и перинатологии. 2005; 4(4): 44—48.

38.   Kim M.D., Kim N.K., Kim H.J., Lee M.HPregnancy following uterine artery embolization with polyvinylalcohol particles for patients with uterine fibroid or adenomyosis. Cardiovasc. Intervent. Radiol. 2005; 5(28): 611-615.

39.   D'Angelo A., Amso N.N., Wood A. Spontaneous multiple pregnancy after uterine artery embolization for uterine fibroid: case report. Eur. J. Obstet. Gynecol. Reprod. Biol. 2003; 2(110): 245-246.

40.   Nabeshima H., Murakami T., Sato Y., Terada Y., Yaegashi N., Okamura K. Successful pregnancy after myomectomy using preoperative adjuvant uterine artery embolization. Tohoku J. Exp. Med. 2003; 3(200): 145-149.

41.   Carpenter T.T., Walker W.J. Pregnancy following uterine artery embolisation for symptomatic fibroids: a series of 26 completed pregnancies. BJOG. 2005; 3(112): 321-325.

42.   Price N., Gillmer M.D., Stock A., Hurley P.A. Pregnancy following uterine artery embolisation. J. Obstet. Gynaecol. 2005; 1(25): 28-31.

43.   Stringer N.H., Grant T., Park J., Oldham L. Ovarian failure after uterine artery embolization for treatment of myomas. J. Am. Assoc. Gynecol. Laparosc. 2000; 3(7): 395-400.

44.   Hascalik S., Celik O., Sarac K., Hascalik M. Transient ovarian failure: a rare complication of uterine fibroid embolization. Acta Obstet. Gynecol. Scand. 2004; 7(83): 682-685.

45.   Payne J.F., Robboy S.J., Haney A.F. Embolic microspheres within ovarian arterial vasculature after uterine artery embolization. Obstet. Gynecol. 2002; 5(100): 883-886.

46.   Healey S., Buzaglo K., Seti L., Valenti D., Tulandi T. Ovarian function after uterine artery embolization and hysterectomy. J. Am. Assoc. Gynecol. Laparosc. 2004; 3(11): 348-352.

47.   Tropeano G., Di Stasi C., Litwicka K., Romano D., Draisci G., Mancuso S. Uterine artery embolization for fibroids does not have adverse effects on ovarian reserve in regularly cycling women younger than 40 years. Fertil. Steril. 2004; 4(81): 1055-1061.

48.   Ahmad A., Qadan L., Hassan N., Najarian K. Uterine artery embolization treatment of uterine fibroids: effect on ovarian function in younger women. J. Vasc. Interv. Radiol. 2002; 10(13): 1017-1020.

49.   Pelage J.P., Walker W.J., Le Dref O., Rymer R. Ovarian artery: angiographic appearance, embolization and relevance to uterine fibroid embolization. Cardiovasc. Intervent. Radiol. 2003; 3(26): 227-233.

50.   Barth M.M., Spies J.B. Ovarian artery embolization supplementing uterine embolization for leiomyomata. J. Vasc. Interv. Radiol. 2003; 9(14): 1177-1182.

51.   Andrews R.T., Bromley P.J., Pfister M.E. Successful embolization of collaterals from the ovarian artery during uterine artery embolization for fibroids: a case report. J. Vasc. Interv. Radiol. 2000; 5(11): 607-610.

52.   YangJ.J., Xiang Y., Wan X.R., Yang X.Y Diagnosis and management of uterine arteriovenous fistulas with massive vaginal bleeding. Int. J. Gynaecol. Obstet. 2005; 2(89): 114-119. 53.Rubod C., Mubiayi N., Robert Y., Vinatier D. Uterine arteriovenous malformation. A rare cause of recurrent metrorrhagia. Gynecol. Obstet. Fertil. 2005; 7-8(33): 511-513.

54.   Lipari C.W., Badawy S.Z. Arteriovenous malformation in a bicornuate uterus leading to recurrent severe uterine bleeding: a case report. J. Reprod. Med. 2005; 1(50): 57-60.

55.   Amagada J.O., Karanjgaokar V, Wood A., Wiener J.J. Successful pregnancy following two uterine artery embolisation procedures for arteriovenous malforma tion. J. Obstet. Gynaecol. 2004; 1(24): 86-87.

56.   Lambert P., Marpeau L., Jan net D. et al. Cervical pregnancy: conservative treatment with primary embolization of the uterine arteries. A case report. Review of the literature. J. Gynecol. Obstet. Biol. Reprod. 1995; 1(24): 43-47.

57.   Suzumori N., Katano K., Sato T. et al. Conservative treatment by angiographic artery embolization of an 11-week cervical pregnancy after a period of heavy bleeding. Fertil. Steril. 2003; 3(80): 617-619.

58.   Sherer D.M., Lysikiewicz A., Abulafia O. Viable cervical pregnancy managed with systemic Methotrexate, uterine artery embolization, and local tamponade with inflated Foley catheter balloon. Am. J. Perinatol. 2003; 5(20): 263-267.

59.   Itakura A., Okamura M., Ohta T., Mizutani S. Conservative treatment of a second trimester cervicoisthmic pregnancy diagnosed by magnetic resonance imaging. Obstet. Gynecol. 2003; 5(101): 1149-1151.

60.   Hong T.M., Tseng H.S., Lee R.C., Wang J.H., Chang C.Y Uterine artery embolization: an effective treat ment for intractable obstetric haemorrhage. Clin. Radiol. 2004; 1(59): 96-101.

61.   Liu X., Fan G., Jin Z., Yang N., Jiang Y., Gai M., Guo L., Wang Y., Lang J. Lower uterine segment pregnancy with placenta increta complicating first trimester induced abortion: diagnosis and conservative management. Chin. Med. J. 2003; 5(116): 695-698.

62.Sugawara J., Senoo M., Chisaka H., Yaegashi N., Okamura K. Successful conservative treatment of a cesarean scar pregnancy with uterine artery embolization. Tohoku J. Exp. Med. 2005; 3(206): 261-265.

63.   Kapranov S.A., Kurtser M.A., Bobrov B.Y., Alieva A.A., Zlatovratsky A.G. Non-fibroid indications for UAE: twelve cases. CIRSE 2006: 244.

 

 Abstract:

 

Material and methods. Study population includes 47 women with arterial hypertension (AH) in the third term of pregnancy.

Results and сonclusion. High grade AG was shown to be associated with high resistive index and thus higher value of total peripheral vascular resistance (TPVR). Bisoprolol and Nifedipin GITS normalize blood pressure and alleviates endothelial dysfunction. Antihypertensive therapy tends to lower TPVR in fetal, placental and uterine circulation providing better flow. 

 

References 

1.      Генералов СИ. Прогнозирование, диагностика и лечение нарушений в системе мать - плацента - плод при заболеваниях сердечно-сосудистой системы. Автореф. дис. д-ра мед. наук. Киев. 1990; 54 с.

2.    Милованов А.И. Патология системы мать - плацента - плод. М.: Медицина. 1999; 446 с.

3.    Демченко Е. Ю. Течение и исход беременности, состояние центральной и маточно-плодово-плацентарной гемодинамики при неосложненном течении беременности и осложнении ее ОПГ-гестозом. Дис. д-ра мед. наук. М. 1996; 477 с.

4.    Hefler L.A. et al. Endothelial-derived nitric oxide and angiotensinogen. Вlood pressure and metabolism during mouse pregnancy. Am.J. Physiol. Regul. Integr. Comp. Physiol. 2001; 280 (10): 174-182.

5.    Шехтман М.М. Руководство по экстрагенитальной патологии у беременных. М.: Триада. 2003; 816 с.

6.    Николаева Е.И., Тахиян А.А. Оценка современных перинатальных технологий у беременных и рожениц высокого риска. Вестник Рос.   ассоц.  акушеров-гинекологов.  2003;1: 26-28. 

7.    Радзинский В.Е. Фармакотерапия плацентарной недостаточности.  Клинич.  фармакол. и терап. 1998; 7 (3): 91-96.

8.    Елисеев О.М.,  Шехтман М.М.  Беременность: дагностика и лечение болезней сердца,    сосудов   и   почек.    Ростов-на-Дону: Феникс. 1997; 640 с.

9.    Киншт Д.Н. Гёстоз как системная воспалительная реакция. Автореф. дис. канд. мед. наук. Новосибирск. 2000; 24 с.

10.  Blatla N. et al. Cardiac disease in pregnancy. Int.J. Gynecol. Obstet. 2003; 82 (10): 153.

11.  Стрижаков А.Н.,  Бунин А.  Т.,  Медведев M.B.,  Григорян Г.А.  Значение допплерометрии маточно-плацентарного и плодово-плацентарного   кровотока   в   выборе рациональной тактики ведения беременной и метода родоразрешения. Акушерство и гинекология. 1991; 3: 23-25.

12.  Bracero L.A. et al. Comparison of umbilical doppler velocimetry, nonstress testing, and biophysical profile in pregnancies complicated by diabetes. J. Ultrasound. Med. 1996; 15:301-308.

13.  Агеева М.И. Допплерометрическое исследование в акушерской практике. М.: Медицина. 2000; 111.

14.  Стрижакова М.А. Клинико-морфологическое обоснование допплерометрического исследования кровотока в маточных артериях при физиологическом и осложненном течении беременности. Автореф. дис.канд. мед. наук. М. 1992; 24 с.

15.  Blackburn S. Maternal, fetal and neonatal physiology. А Clinical perspective. St. Louis: Saunders. 2003; 360 с.

 16. Elkayam U. Pregnancy and cardiovascular disease. Ed. E. Braunwald. Heart disease: a textbook of cardiovascular medicine. 6-th ed. Philadelphia. 2001; 2181.

17.  Abalos E. et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy (Cochrane Review).  Coch. Datab. Syst. Rev. 2007; 1: 53-61.

18.  Perloff J.K. Pregnancy in women with congenital heart disease. Specific lesions. Режим доступа: http://www. uptodate. com.

19.  Макацария А.Д.,   Султанова И.О.,   Смирнова Л.М. Дифференциальная диагностика и принципы профилактики тромбоэмболических осложнений у беременных с искусственными клапанами сердца. Акуш. и гин. 1991; 11: 28-33.

20.  Свечников П.Д.  Маркеры повреждения эндотелия при беременности,  осложненной гестозом. Автореф. дис.  канд.  мед.наук. С.-Пб. 2000; 50 с.

21.  Радзинский В.Е., Смалько П.Я. Биохимия плацентарной недостаточности. М.: Медицина. 2001; 180 с.

22.  Alexander B. T. et al. Differential expression of renal nitric oxide synthase isoforms during pregnancy    in    rats.    Hypertension.     1999; 33 (4): 435-439.

23.  Brooks V.L. et al. Does nitric oxide contribute to the basal vasodilation of pregnancy in conscious rabbits? Am. J.  Physiol.  Regul.  Integr. Comp. Physiol. 2001; 281 (12): 1624-1632.

24.  Мартынов А.И., Аветяк Н.Г., Акатова Е.В. и    др.    Эндотелиальная    дисфункция и методы ее определения. Рос.  кардиол.  ж.2005; 4: 94-98.

 

 

Abstract:

Aim: was to estimate ultrasound signs of placental insufficiency in women whose pregnancy was the result of extracorporeal fertilization (ECF) and embryo replanting.

Materials and methods: the study involved 84 women who became pregnant as a result of ECF and replanting embryos. Terms of pregnancy were 18-40 weeks. Age of women was from 24 to 46 years. Ultrasound examination was performed by standard methods recommended for pregnant women, with an estimation of basic fetal metric parameters and their compliance with the term of pregnancy, the heart rate of the fetus, the degree of maturity of the placenta, thickness, location and sonographic features of the placenta (calcifications, cysts, heart attacks, expand the intervillous space varying degrees of severity) the quantity and quality of amniotic fluid.

Results: during ultrasound of women whose pregnancy was the result of ECF and embryos replanting, in 38 (35.6%) patients pathological changes in the placenta were diagnosed. It is evident in discrepancy of placenta maturity for a full-term pregnancy The combination of 3 or more of features identified during the ultrasound examination may indicate the development of placental insufficiency in women after ECF. Ultrasound features include: the degree of maturity mismatch placenta given gestational age; the thickness of the placenta; violation of utero-placental or fetus-placental blood flow; fetal growth retardation; amount of water.

 

References

1.     Nazarenko T.A., Suhih G.T. Besplodnyj brak. Sovremennye podhody i lechenie. Biblioteka vracha specialista [Infertility. Modern approaches and treatment. Library of doctor-specialist.]. Moskva, 2010; 11-20 [In Russ].

2.     Jakovenko E.M., Jakovenko S.A. Besplodie [Infertility]. Moskva. 2009; 197-198 [ In Russ].

3.     Kapustina M.V., Krasnopol'skij V.I. Ocenka vlijanija na vybor metoda razreshenija pri inducirovannoj beremennosti faktorov, svjazannyh s prichinoj i dlitel'nost'ju besplodija, vozrastom pacientok i kolichestvom vypolnennyh procedur jekstrakorporal'nogo oplodotvorenija [Estimation of influence on delivery method in case of induces pregnancy with factors, communicated with reason and duration of infertility, age of patients, and amount of proceed extracorporeal fertilization.]. Rossijskij vestnik akushera-ginekologa. 2011; 2: 44-48 [In Russ].

4.     Zhou C., KnightD.C., Tyler J.P et al. Factors affecting pregnancy outcome resulting from assisted reproductive technology (ART). J. Obstet. Gynaecol. Res. 1998; 24(5): 343-350.

5.     Тогок O., Lapinski R., Salafia C. M., Beraasko J., Berkowitz R.L. Multifetal pregnancy reduction is not associated with an increased risk of intrauterine growth restriction, except for very-high-order multiples. J. Obstet. Gynecol. 1998; 179: 221-225.

6.     Tunon K., Eik-Nes S.H., Grottum P et al. Gestational age in pregnancies conceived after in vitro fertilization: a comparison between age assessed from oocyte retrieval, crown-rump length and biparietal diameter. Ultrasound Obstet. Gynecol. 2000; 15(1): 41-47.

7.    Makarov I.O. Vedenie beremennosti posle primenenija vspomogatel'nyh reproduktivnyh tehnologij [Pregnancy supervision, after assistance of special reproductive technologies.]. M: 2010; 2: 44-48 [In Russ].

8.     Wennerholm U-B., Berg C., Hagberg H. et al. Gestational age in pregnancies after in vitro fertilization: comparison between ultrasound measurements and actual age. Ultrasound Obstet. Gynecol. 1998; 12: 170-174.

9.     Novikova S.V., Tumanova V.A., Krasnopol'skij V.I. Kompensatornye mehanizmy razvitija ploda v uslovijah placentarnoj nedostatochnosti [Compensatory mechanisms of fetal development in case of placental insufficiency]. Moskva. 2008; 7-15 [In Russ].

10.   Vnutriutrobnoe razvitie cheloveka [Natak development of human]. Moskva. 2006; 137-156[In Russ].

11.   Милованов А.П. Патология системы мать-плацента-плод. Руководство для врачей. Медицина. 2006; 7-153.

Milovanov A.P. Patologija sistemy mat'-placenta-plod. Rukovodstvo dlja vrachej [Patology of system «mother-placenta-fetus». Guide-book for doctors]. Medicina. 2006; 7-153 [In Russ].

12.   Krasnopol'skij V.I. Klinicheskaja, ul'trazvukovaja i morfologicheskaja harakteristika hronicheskoj placentarnoj nedostatochnosti [Clinical ultrasound and morphological characteristics of chronic placental insufficiency]. Akusherstvo i ginekologija. 2006; 1: 13-16 [In Russ].

13.   Granum P.A. Ultrasound examination of the placenta. Clin Obstet Gynaecol. 1983; 10(3): 459-473.

14.   Ivanec T.Ju. Vlijanie stimuljacii superovuljacii na gemostaz pri jekstrakorporal'nom oplodotvorenii i perenose jembriona v polost' matki: Avt.diss. kand. med.nauk. M.[Influence of superovulation stimulation on hemostasis in case of extracorporeal fertilization and embryo replanting in uterine cavity], 2004; 24 s [In Russ].

15.   Lenz S., Lauritsen J.G. Ultrasonically guided percutaneous aspiration of human follicles under local anesthesia: a new method of collecting oocytes for in vitro fertilization. Fertil. Steril. 2010; 6(2): 229-245.

16.   Huisman G.J., Fauser B.C.J.M., Eijkemans M.J.C. et al. Implantation rates after in vitro fertilization and transfer of a maximum of two embryos that undergone three to five days of culture. Fert. Ster. 2000; 73(1): 117-123.

17.   Kokolina V.F., Kartelishev A.F., Vasil'eva O.A. Fetoplacentarnaja nedostatochnost'. Rukovodstvo dlja vrachej [Fetoplacental insufficiency]. Moskva. 2006; 11-197[In Russ].

18.   Koudstaal J., Bruinse H.W., Helmerhorst F.M. et al. Obstetric outcome of twin pregnancies after in-vitro fertilization: a matched control study in four  DutchUniversity hospitals. Hun. Reprod. 2000; 15(4): 935-940.

19.   Mit'kov M.M., Medvedev M.V. Klinicheskoe rukovodstvo po ul'trazvukovoj diagnostike [Clinical guidebook: ultrasound diagnostics]. Moskva. Vidar. 1996; 2: 73-75 [In Russ].

20.   Artur Flejsher, Roberto Romero, Frjenk Menning, Filipp Dzhenti. Jehografija v akusherstve i ginekologii [Echography in obstetrics and gynecology]. Moskva. Vidar. 2005; 1: 447-458 [In Russ].

21.   Medvedev M.V., Judina E.V. Differencial'naja ul'trazvukovaja diagnostika v akusherstve [Differential ultrasound diagnostics in obstetrics]. Moskva. Vidar. 1997; 154-306 [In Russ].

22.   Guimarilis Fitho H.A., Araujo Junior E., Mattar R., et.al. Placental blood flow measured by three-dimensional power Doppler ultrasound at 26 to 35 weeks gestation in normal pregnancies. Fetal Neonatal Med. 2010; 23(1): 69-73.

23.   Bernirschke K., Kaufmann P. Pathology of the human placenta. New York: Springer-Verlag. 2000; 353-359.

24.  Makarov I.O., Judina E.V., Borovkova E.I. Zaderzhka rosta ploda [Fetal growth retardation]. Moskva, 2012; 54 [In Russ].

25.   Ya C.K.H., Khouri O., Onwudiwe N., et.al. Prediction of pre-eclampsia by uterine artery Doppler imaging relationship to gestation age at delivery and smallfor gestational age. Ultrasound Obstet. Gynecol. 2008; 31(3): 310-313.

26.   Radzinskij V. E

ANGIOLOGIA.ru (АНГИОЛОГИЯ.ру) - портал о диагностике и лечении заболеваний сосудистой системы